NDC 0008-4001 – Protonix I.V.
Pantoprazole Sodium 40 mg/10mL · Injection, Powder, For Solution · Intravenous
Product NDC0008-4001
Product details
- Brand name
- Protonix I.V.
- Generic name
- Pantoprazole Sodium
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Dosage form
- Injection, Powder, For Solution
- Route
- Intravenous
- Marketing category
- NDA · NDA020988
- Marketed since
- May 1, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Proton Pump Inhibitor
Active ingredients
- Pantoprazole Sodium 40 mg/10mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0008-4001-10 | 10 CARTON in 1 PACKAGE (0008-4001-10) / 1 VIAL in 1 CARTON (0008-4001-01) / 10 mL in 1 VIAL | May 1, 2013 |
| 0008-4001-25 | 25 CARTON in 1 PACKAGE (0008-4001-25) / 1 VIAL in 1 CARTON (0008-4001-01) / 10 mL in 1 VIAL | May 1, 2013 |
Recalls mentioning this NDC
- D-0516-2017 Mar 22, 2017 · Class III
Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.
Other Protonix products
- 55154-4225 Pantoprazole Sodium 40 mg/10mL · Injection, Powder, For Solution · Cardinal Health 107, LLC
- 55154-4236 Pantoprazole Sodium 40 mg/10mL · Injection, Powder, For Solution · Cardinal Health 107, LLC
- 0008-0923 Pantoprazole Sodium 40 mg/10mL · Injection, Powder, For Solution · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- 0008-0841 Pantoprazole Sodium 40 mg/1 · Tablet, Delayed Release · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- 0008-0843 Pantoprazole Sodium 20 mg/1 · Tablet, Delayed Release · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- 0008-0844 Pantoprazole Sodium 40 mg/1 · Granule, Delayed Release · Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.